BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30664709)

  • 1. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism.
    Liu T; Barrett NA; Kanaoka Y; Buchheit K; Laidlaw TM; Garofalo D; Lai J; Katz HR; Feng C; Boyce JA
    Mucosal Immunol; 2019 May; 12(3):679-690. PubMed ID: 30664709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
    Liu T; Barrett NA; Kanaoka Y; Yoshimoto E; Garofalo D; Cirka H; Feng C; Boyce JA
    J Immunol; 2018 Feb; 200(3):915-927. PubMed ID: 29282304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene D
    Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA
    J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.
    Liu T; Laidlaw TM; Katz HR; Boyce JA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16987-92. PubMed ID: 24085850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
    Liu T; Kanaoka Y; Barrett NA; Feng C; Garofalo D; Lai J; Buchheit K; Bhattacharya N; Laidlaw TM; Katz HR; Boyce JA
    J Immunol; 2015 Oct; 195(8):3537-45. PubMed ID: 26342029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors.
    Liu T; Garofalo D; Feng C; Lai J; Katz H; Laidlaw TM; Boyce JA
    J Immunol; 2015 Jun; 194(11):5061-8. PubMed ID: 25904552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor.
    Cummings HE; Liu T; Feng C; Laidlaw TM; Conley PB; Kanaoka Y; Boyce JA
    J Immunol; 2013 Dec; 191(12):5807-10. PubMed ID: 24244016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.
    Laidlaw TM; Kidder MS; Bhattacharyya N; Xing W; Shen S; Milne GL; Castells MC; Chhay H; Boyce JA
    Blood; 2012 Apr; 119(16):3790-8. PubMed ID: 22262771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CysLT
    Voisin T; Perner C; Messou MA; Shiers S; Ualiyeva S; Kanaoka Y; Price TJ; Sokol CL; Bankova LG; Austen KF; Chiu IM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-1 mediates IL-33-induced extracellular signal-regulated kinase activation in mast cells: Implications for aspirin sensitivity.
    Pan D; Buchheit KM; Samuchiwal SK; Liu T; Cirka H; Raff H; Boyce JA
    J Allergy Clin Immunol; 2019 Mar; 143(3):1047-1057.e8. PubMed ID: 30017554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
    Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
    J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease.
    Foer D; Amin T; Nagai J; Tani Y; Feng C; Liu T; Newcomb DC; Lai J; Hayashi H; Snyder WE; McGill A; Lin A; Laidlaw TM; Niswender KD; Boyce JA; Cahill KN
    J Immunol; 2023 Dec; 211(12):1806-1813. PubMed ID: 37870292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
    Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
    Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between leukotriene C4 and interleukin 13 signaling pathways in a mouse model of airway disease.
    Chavez J; Young HW; Corry DB; Lieberman MW
    Arch Pathol Lab Med; 2006 Apr; 130(4):440-6. PubMed ID: 16594735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
    Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
    Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
    Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
    Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
    J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.
    Picado C; Mullol J; Roca-Ferrer J
    J Allergy Clin Immunol; 2023 Feb; 151(2):310-313. PubMed ID: 36126795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.
    Rusznak M; Peebles RS
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):38-45. PubMed ID: 30516547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.